Short answer · Medically reviewed summary · Last updated: 2026-04-07
Hirschsprung disease was first formally characterized by Danish pediatrician Harald Hirschsprung in 1886, though historical accounts of the condition date back to the 17th century. Over the last century, our understanding has shifted from viewing it as a mechanical obstruction to identifying it as a neurocristopathy—a failure of nerve cells to migrate correctly during fetal development—which has revolutionized surgical approaches and genetic screening. Who first described Hirschsprung disease? While cases of infants with severe abdominal distension were noted as early as 1691 by Frederik Ruysch, it was not until 1886 that Harald Hirschsprung provided the first comprehensive clinical description.
3 people with Hirschsprung Disease have shared their first-person experience on this question at DiseaseMaps.
Hirschsprung disease was first formally characterized by Danish pediatrician Harald Hirschsprung in 1886, though historical accounts of the condition date back to the 17th century. Over the last century, our understanding has shifted from viewing it as a mechanical obstruction to identifying it as a neurocristopathy—a failure of nerve cells to migrate correctly during fetal development—which has revolutionized surgical approaches and genetic screening.
While cases of infants with severe abdominal distension were noted as early as 1691 by Frederik Ruysch, it was not until 1886 that Harald Hirschsprung provided the first comprehensive clinical description. He presented two infants who died from chronic constipation and massive enlargement of the colon, a condition he termed "congenital megacolon." For decades, the disease was simply referred to by his name. It was not until the 1940s that researchers Orvar Swenson and Alexander Bill identified the true underlying pathology: the absence of ganglion cells (nerve cells) in the distal bowel wall, which prevents the colon from relaxing and moving stool forward.
Historically, Hirschsprung disease was often misdiagnosed or attributed to diet and poor hygiene. Before the discovery of the missing ganglion cells, treatment was limited to palliative measures, such as colonic enemas or rectal dilations, which rarely provided long-term relief. The mid-20th century marked a paradigm shift when surgeons realized that removing only the "dilated" portion of the bowel was ineffective because the actual problem was the "narrow" segment downstream that lacked nerve function. This led to the development of the "pull-through" procedure, a landmark milestone that remains the gold standard for treating Hirschsprung disease today.
The evolution of surgical techniques has drastically improved outcomes for patients with Hirschsprung disease. Key historical milestones include:
Today, Hirschsprung disease is understood as a complex genetic condition. We now know it occurs in approximately 1 in 5,000 live births. Genetic research has shown that while the majority of cases are sporadic, some are hereditary. The integration of advanced diagnostics, such as suction rectal biopsy, has replaced outdated and more invasive testing methods. With 591 members currently sharing their experiences on DiseaseMaps.org, the community has become a vital resource for understanding the long-term quality of life and the psychological impacts of living with a chronic gastrointestinal condition.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.